Stimulation of human neutrophil Fc receptor-mediated phagocytosis by a low molecular weight cytokine.
Open Access
- 1 August 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 137 (3) , 868-875
- https://doi.org/10.4049/jimmunol.137.3.868
Abstract
Human neutrophil Fc receptor-mediated phagocytosis can be markedly enhanced by a low m.w. (less than 10,000) heat-labile cytokine(s) derived from specifically stimulated human mononuclear cells and from a human T cell line, MO(t). PMN incubated with supernatant from control mononuclear leukocyte (MNL) culture bound EIgG (percentage of rosettes = 73.7% +/- 7.1) but did not ingest the attached targets (phagocytic index, PI = 40.7 +/- 9.5) as efficiently as PMN incubated with supernatant from adherent MNL, which had ingested EIgG and were then cocultured with nonadherent MNL (PI = 264.3 +/- 46.3). Cytokine-containing supernatants were fractionated on YM-10 Centricon microconcentrators, and the effluent (YM-10E) was found to contain the phagocytosis-enhancing activity. Optimal Fc receptor-mediated ingestion by YM-10E-stimulated PMN required a critical level of target-bound IgG; stimulation was dose dependent and detectable after 5 min at 37 degrees C with a maximal response by 15 min. Monoclonal antibody 3G8 (anti-PMN Fc receptor) inhibited in a dose-dependent fashion both Fc receptor-mediated rosette formation and ingestion by nonstimulated and YM-10E-stimulated PMN. Solid-phase 3G8 Fab had the same effect. A previously undescribed monoclonal antibody, 1C2, exhibited a different pattern of inhibition. It had no effect on rosetting or ingestion of EIgG by nonstimulated PMN; however, it inhibited EIgG phagocytosis by YM-10E-stimulated PMN down to the level of nonstimulated ingestion without affecting rosette formation. Solid-phase 1C2 had the same effect. These data indicate that phagocytosis mediated by 3G8-positive Fc receptors may be enhanced by cytokine(s) stimulation in a manner requiring the molecule recognized by 1C2. Monoclonal antibodies to the alpha-chain of CR3 had only minimal effects on YM-10E-stimulated ingestion. Fluorescence flow cytometry of YM-10E-stimulated PMN, indirectly stained with 3G8 or 1C2, indicated that cytokine enhancement of EIgG ingestion occurred without an increase in either 3G8 or 1C2 binding sites. These data show that the low avidity Fc receptor, which binds immune complexes, may be functionally modulated at sites of inflammation where PMN and macrophages mediate clearance and destruction of immune complexes and opsonized particles.This publication has 11 references indexed in Scilit:
- Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.Journal of Clinical Investigation, 1984
- Human peritoneal macrophages possess two populations of IgG Fc receptorsCellular Immunology, 1984
- Studies on the fibronectin receptors of human peripheral blood leukocytes. Morphologic and functional characterization.The Journal of Experimental Medicine, 1984
- Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.The Journal of Immunology, 1983
- Lymphokines secreted by an established lymphocyte line modulate receptor-mediated endocytosis in macrophages derived from human monocytes.The Journal of Immunology, 1983
- Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes.The Journal of Experimental Medicine, 1983
- Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes.The Journal of Experimental Medicine, 1982
- The Binding of Human Immunoglobulin G1 Monomer and Small, Covalently Cross-Linked Polymers of Immunoglobulin G1 to Human Peripheral Blood Monocytes and Polymorphonuclear LeukocytesJournal of Clinical Investigation, 1982
- HUMAN MONOCYTE, LYMPHOCYTE, AND GRANULOCYTE ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TOWARD TUMOR-CELLS .1. GENERAL-CHARACTERISTICS OF CYTOLYSIS1979
- T-Lymphocyte Variant of Hairy-Cell LeukemiaAnnals of Internal Medicine, 1978